Molecular characterization of hsp90 isoforms in colorectal cancer cells and its association with tumour progression

International Journal of Oncology

Volumn 32, Issue 6, 2008, Pages 1169-1178

  Milicevic, Z ^a   Bogojevic, Desanka ^b   Mihailovic, M ^b   Petrovic, M ^b   Krivokapic, Z ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Institute for Biological Research   (Serbia)

^c CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Colorectal cancer; hsp90; Malignant progression

Indexed keywords

HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 ALPHA; HEAT SHOCK PROTEIN 90 BETA; HEAT SHOCK PROTEIN 90N; UNCLASSIFIED DRUG; ISOPROTEIN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CELL MEMBRANE; CELL MIGRATION; CELL NUCLEUS; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; CYTOSOL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TUMOR DIFFERENTIATION; UPREGULATION; WESTERN BLOTTING; ADENOCARCINOMA; CELL DIFFERENTIATION; CELL MOTION; COLORECTAL TUMOR; DISEASE COURSE; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROGNOSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL MEMBRANE; CELL MOVEMENT; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HSP90 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION;

EID: 48149106036     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo_32_6_1169     Document Type: Article

References (79)

1. Maloney A and Workman P: Hsp90 as a new therapeutic target for cancer therapy: the story unfolds. Expert Opin Biol Ther 2: 3-24, 2002.
2. Soti C, Pal C, Papp B and Csermely P: Molecular chaperones as regulatory elements of cellular networks. Curr Opin Cell Biol 17: 210-215, 2005.
3. Y-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc Natl Acad Sci USA 91: 8324-8328, 1994.
4. Vilenchik M, Solit D, Basso A, et al: Targeting wide-range oncogenic transformation via PU24FCI, a specific inhibitor of tumor hsp90. Chem Biol 11: 787-797, 2004.
5. Blagosklonny MV: Hsp90-associated oncoproteins: multiple targets of geldanamycin and its analogs. Leukemia 16: 455-462, 2002.
6. Pratt WB and Toft DO: Regulation of signalling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med 228: 111-133, 2003.
7. Workman P: Altered states: selectively drugging the hsp90 cancer chaperone. Trends Mol Med 10: 47-51, 2004.
8. Workman P: Combinatorial attack on multistep oncogenesis by inhibiting the hsp90 molecular chaperone. Cancer Lett 206: 149-157, 2004.
9. Pearl LH and Prodromou C: Structure, function, and mechanism of the hsp90 molecular chaperone. Adv Protein Chem 59: 157-185, 2002.
10. Grammatikakis N, Vultur A, Ramana CV, Siganou A, Schweinfest CW, Watson DK and Raptis L: The role of hsp90N, a new member of the hsp90 family, in signal transduction and neoplastic transformation. J Biol Chem 277: 8312-8320, 2002.
11. Karin M and Hunter T: Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr Biol 5: 747-757, 1995.
12. Angel P and Karin M: The role of jun, fos and the AP-1 complex in cell proliferation and transformation. Biochim Biophys Acta 1072: 129-157, 1991.
13. Goetz MP, Toft DO, Ames MM and Erlichman C: The hsp90 chaperone complex as a novel target for cancer therapy. Ann Oncol 14: 1169-1176, 2003.
14. Pandey P, Saleh A, Nakazawa A, et al: Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat-shock protein 90. EMBO J 19: 4310-4322, 2000.
15. Mason AB, Burkitt M, Magee CJ, O'Connor D and Greenhalf W: The role of hsp90 in regulation of apoptosis in pancreatic cancer. Br J Cancer 85: 54-55, 2001.
16. Munster PN, Basso A, Solit D, Norton L and Rosen N: Modulation of hsp90 function by ansamycins sensitizes breast-cancer cells to chemotherapy-induced apoptosis in an Rb-dependent and schedule-dependent manner. Clin Cancer Res 7: 2228-2236, 2001.
17. Hostein I, Robertson D, Distefano F, Workman P and Clarke PA: Inhibition of signal-transduction by the hsp90 inhibitor 17-allylamine-17-demethoxygeldanamycin results in cytostasis and apoptosis. Cancer Res 61: 4003-4009, 2001.
18. Gebhard B, Schutz G, Ecker RC, Steiner GE, Rudas M, Gnant M and Oehler R: MHC-class-I expression in human breast cancer correlates with nuclear localization of the 90 kDa heat-shock-protein. Anticancer Res 19: 5293-5298, 1999.
19. Jolly C and Morimoto RI: Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst 92: 1564-1572, 2000.
20. Yamada T, Hashiguchi A, Fukushima S, Kakita Y, Umezawa A, Maruyama T and Hata J-I: Function of 90 kDa heat shock protein in cellular differentiation of human embryonal carcinoma cells. In Vitro Cell Dev Biol Anim 36: 139-146, 2000.
21. Helmbrecht K, Zeise E and Rensing L: Chaperones in cell cycle regulation and mitogenic signal transduction. Cell Prolif 33: 341-365, 2000.
22. Morson BC and Sobin LH: Histological typing of intestinal tumors. In: International Histological Classification of Tumor. No. 15, WHO, Geneva, 1976.
23. Blobel G and Potter VR: Nuclei from rat liver: isolation, method that combines purity with high yield. Science 154: 1662-1665, 1966.
24. Bauer HC and Hurtenbach U: Murine cortical brain cells are autoantigenic from a distinct developmental stage onwards. J Neuroimmunol 12: 1-13, 1986.
25. Lowry OH, Rosenbrough NJ, Farr AL and Ransdall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275, 1951.
26. Pennial R: An improved method for the determination of inorganic phosphate by the isobutanol-benzene extraction procedure. Anal Biochem 14: 87-90, 1966.
27. 2+)-ATPase activity in plasma membrane fragments isolated from squid nerves. Biochim Biophys Acta 644: 147-152, 1981.
28. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277: 680-685, 1970.
29. Towbin H, Staechelin T and Gordon J: Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979.
30. Riehl RM, Sulivan WP, Vroman BT, Bauer VJ, Pearson GR and Toft DO: Immunological evidence that the non-hormone binding component of avian steroid receptors exists in a wide range of tissues and species. Biochemistry 24: 6585-6591, 1985.
31. Midgley R and Kerr D: Colorectal cancer. Lancet 353: 391-399, 1999.
32. Arends WJ: Molecular interactions in the Vogelstein model of colorectal carcinoma. J Pathol 190: 412-416, 2000.
33. Watanabe T and Muto T: Colorectal carcinogenesis based on molecular biology of early colorectal cancer, with special reference to nonpolypoid (superficial) lesions. World J Surg 24: 1091-1097, 2000.
34. Takayama T, Miyanishi K, Hayashi T, Sato Y and Nirrsu Y: Colorectal cancer: genetics of development and metastasis. J Gastroenterol 41: 185-192, 2006.
35. Calderwood SK, Khaleque MA, Sawyer DB and Ciocca DR: Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci 31: 164-172, 2006.
36. Chiosis G: Targeting chaperones in transformed system - a focus on hsp90 and cancer. Expert Opin Ther Targets 10: 37-50, 2006.
37. Kohda T, Kondo K and Oishi M: Cellular hsp90 (hsp86) mRNA level and in vitro differentiation of mouse embryonal carcinoma (F9) cells. FEBS Lett 290: 107-110, 1991.
38. Maruyama T, Umezawa A, Kusakari S, Kikuchi H, Nozaki M and Hata J: Heat shock induces differentiation of human embryonal carcinoma cells into trophectoderm lineages. Exp Cell Res 224: 123-127, 1996.
39. Csermely P, Kajtar J, Hollosi M, Oikarinen J and Somogyi J: The 90 kDa heat shock protein (hsp90) induces the condensation of the chromatin structure. Biochem Biophys Res Commun 202: 1657-1663, 1994.
40. Pal JK, Anand S and Joseph J: Association of hsp90 with the heme-regulated eukaryotic initiation factor 2α kinase-a collaboration for regulating protein synthesis. J Biosci 21: 191-205, 1996.
41. Wiech H, Buchner J, Zimmermann R and Jakob U: Hsp90 chaperones protein folding in vitro. Nature 358: 169-170, 1992.
42. Pratt WB: The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor. J Biol Chem 268: 21455-21458, 1993.
43. Jérôme V, Vourch C, Baulieu EE and Catelli MG: Cell cycle regulation of the chicken hsp90α expression. Exp Cell Res 205: 44-51, 1993.
44. Galea-Lauri J, Latchman DS and Katz DR: The role of the 90 kDa heat shock protein in cell cycle control and differentiation of the monoblastoid cell line U937. Exp Cell Res 226: 243-254, 1996.
45. Catelli MG, Ramachandran C, Gauthier Y, Legagneux V, Quelard C, Baulieu EE and Shyamala G: Developmental regulation of murine mammary-gland 90 kDa heat-shock proteins. Biochem J 258: 895-901, 1989.
46. Sass JB, Weinberg ES and Krone PH: Specific localization of zebrafish hsp90α during normal muscle development. Mech Dev 54: 195-204, 1996.
47. Pratt WB: The hsp90-based chaperone system: involvement in signal transduction from a variety of hormone and growth factor receptors. Proc Soc Exptl Biol Med 217: 420-434, 1998.
48. Blagosklonny MV, Toretsky J, Bohen S and Neckers L: Mutant conformation of p53 translated in vitro or in vivo requires functional hsp90. Proc Natl Acad Sci USA 93: 8379-8383, 1996.
49. Sepehrnia B, Paz IB, Dasgupta G and Momand J: Heat-shock protein 84 forms a complex with mutant p53 protein predominantly within a cytoplasmic compartment of the cell. J Biol Chem 271: 15084-15090, 1996.
50. Teng SC, Chen YY, Su YN, Chou PC, Chiang YC, Tseng SF and Wu KJ: Direct activation of hsp90A transcription by c-Myc contributes to c-Myc-induced transformation. J Biol Chem 279: 14649-14655, 2004.
51. Lebeau J, Le Chalony C, Prosperi MT and Goubin G: Constitutive overexpression of a 89 kDa heat shock protein gene in the HBL100 human mammary cell line converted to a tumorigenic phenotype by the EJ/T24 Harvey-ras oncogene. Oncogene 6: 1125-1132, 1991.
52. Yufu Y, Nishimura J and Nawata H: High constitutive expression of heat shock protein 90α in human acute leukemia cells. Leuk Res 16: 597-605, 1992.
53. Neckers L and Ivy SP: Heat shock protein 90. Curr Opin Oncol 15: 419-424, 2003.
54. Gabai VL and Kabakov AE: Induction of heat-shock protein synthesis and thermotolerance in EL-4 ascites tumor cells by transient ATP depletion after ischemic stress. Exp Mol Pathol 60: 88-99, 1994.
55. Legagneux V, Mezger V, Quelard C, Barnier JV, Bensaude O and Morange M: High constitutive transcription of hsp86 gene in murine embryonal carcinoma cells. Differentiation 41: 42-48, 1989.
56. Ferrarini M, Heltai S, Zocchi MR and Rugarli C: Unusual expression and localization of heat-shock proteins in human tumor cells. Int J Cancer 51: 613-619, 1992.
57. Gabai VL, Mosina VA, Budagova KR and Kabakov AE: Spontaneous overexpression of heat-shock proteins in Ehrlick ascites carcinoma cells during in vivo growth. Biochem Mol Biol Int 35: 95-102, 1995.
58. Chant ID, Rose PE and Morris AG: Analysis of heat-shock protein expression in myeloid leukaemia cells by flow cytometry. Br J Haematol 90: 163-168, 1995.
59. Pia Protti M, Heltai S, Bellone M, Ferrarini M, Manfredi AA and Rugarli C: Constitutive expression of the heat shock protein 72 kDa in human melanoma cells. Cancer Lett 85: 211-216, 1994.
60. Ehrenfried JA, Herron BE, Townsend CM and Evers BM: Heat shock proteins are differentially expressed in human gastrointestinal cancers. Surg Oncol 4: 197-203, 1995.
61. Mileo AM, Fanuele M, Battaglia F, Scambia G, Benedetti-Panici P, Mancuso S and Ferrini U: Selective overexpression of mRNA coding for 90 kDa stress-protein in human ovarian cancer. Anticancer Res 10: 903-906, 1990.
62. Gress TM, Muller-Pillasch F, Weber C, et al: Differential expression of heat shock proteins in pancreatic carcinoma. Cancer Res 54: 547-551, 1994.
63. Nanbu K, Konishi I, Komatsu T, et al: Expression of heat shock proteins hsp70 and hsp90 in endometrial carcinomas. Correlation with clinicopathology, sex steroid receptor status, and p53 protein expression. Cancer 77: 330-338, 1996.
64. Menoret A, Meflah K and Le Pendu J: Expression of the 100 kDa glucose-regulated protein (GRP100/endoplasmin) is associated with tumorigenicity in a model of rat colon adenocarcinoma. Int J Cancer 56: 400-405, 1994.
65. Cai JW, Henderson BW, Shen JW and Subjeck JR: Induction of glucose regulated proteins during growth of a murine tumor. J Cell Physiol 154: 229-237, 1993.
66. Jameel A, Skilton RA, Campbell TA, Chander SK, Coombes RC and Ligmani YA: Clinical and biological significance of hsp89α in human breast cancer. Int J Cancer 50: 409-415, 1992.
67. Franzen B, Linder S, Alaiya AA, et al: Analysis of polypeptide expression in benign and malignant human breast lesions-down regulation of cytokeratins. Br J Cancer 74: 1632-1638, 1996.
68. Haverty AA, Harmey JH, Redmond HP and Bouchier-Hayes DJ: Interleukin-6 upregulates gp96 expression in breast cancer. J Surg Res 69: 145-149, 1997.
69. Yano M, Naito Z, Tanaka S and Asano G: Expression and roles of heat shock proteins in human breast cancer. Jpn J Cancer Res 87: 908-915, 1996.
70. Luparello C and Noel A: Pucciminafra I. Intratumoral heterogeneity for hsp90B mRNA levels in a breast cancer cell line. DNA Cell Biol 16: 1231-1236, 1997.
71. Denis MG, Chadeneau C, Blanchardie P and Lustenberger P: Biological effects of glucocorticoid hormones on two rat colon adenocarcinoma cell lines. J Steroid Biochem Mol Biol 41: 739-745, 1992.
72. Landers JP and Spelsberg TC: New concepts in steroid hormone action: transcription factors, proto-oncogenes, and the cascade model for steroid regulation of gene expression. Crit Rev Eukaryot Gene Expr 2: 19-63, 1992.
73. Bertram J, Palfner K, Hiddemann W and Kneba M: Increase of P-glycoprotein mediated drug resistance by hsp90β. Anticancer Drugs 7: 838-845, 1996.
74. Jolly C, Michelland S, Rocchi M, Robert-Nicoud M and Vourch C: Analysis of the transcriptional activity of amplified genes in tumour cells by fluorescence in situ hybridization. Hum Genet 101: 81-87, 1997.
75. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman FM and Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821, 1992.
76. Basu S, Binder RJ, Ramalingam T and Srivastava PK: CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14: 303-313, 2001.
77. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000.
78. Eustace BK, Sakurai T, Steward JK, et al: Functional proteomic screens reveal an extracellular role for hsp90 alpha in cancer cell invasiveness. Nat Cell Biol 6: 507-514, 2004.
79. Picard D: Hsp90 invades the outside. Nat Cell Biol 6: 479-480, 2004.